
George J. Marlo
Examiner (ID: 3509)
| Most Active Art Unit | 3304 |
| Art Unit(s) | 3304, 2102, 3711, 3305 |
| Total Applications | 2473 |
| Issued Applications | 2233 |
| Pending Applications | 77 |
| Abandoned Applications | 163 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17369970
[patent_doc_number] => 20220025022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/358669
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358669
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358669 | Anti-ETEC adhesin protein antibodies and methods of use | Jun 24, 2021 | Issued |
Array
(
[id] => 18496122
[patent_doc_number] => 20230218666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ANTIMICROBIAL COMBINATIONS
[patent_app_type] => utility
[patent_app_number] => 18/002203
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002203
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002203 | ANTIMICROBIAL COMBINATIONS | Jun 17, 2021 | Pending |
Array
(
[id] => 18510076
[patent_doc_number] => 20230226175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => MODIFIED EXOTOXIN A PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/001498
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001498
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001498 | MODIFIED EXOTOXIN A PROTEINS | Jun 16, 2021 | Pending |
Array
(
[id] => 18496181
[patent_doc_number] => 20230218735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => IMMUNOGENIC COMPOSITIONS AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/001953
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001953
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001953 | Immunogenic compositions against | Jun 16, 2021 | Issued |
Array
(
[id] => 18647880
[patent_doc_number] => 20230293657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/001525
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001525
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001525 | VACCINE | Jun 16, 2021 | Pending |
Array
(
[id] => 17445350
[patent_doc_number] => 20220065855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => DIAGNOSTIC
[patent_app_type] => utility
[patent_app_number] => 17/348428
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348428 | Method of detecting | Jun 14, 2021 | Issued |
Array
(
[id] => 17214809
[patent_doc_number] => 20210348146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => CHIMERIC BACTERIOPHAGE LYSIN WITH ACTIVITY AGAINST STAPHYLOCOCCI BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/328299
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/328299 | Chimeric bacteriophage lysin with activity against | May 23, 2021 | Issued |
Array
(
[id] => 18496139
[patent_doc_number] => 20230218685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOSITION FOR PROMOTING INTESTINAL TRACT DEVELOPMENT, COMPOSITION FOR IMPROVING PULMONARY FUNCTION AND COMPOSITION FOR ENHANCING IMMUNE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/999451
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999451 | COMPOSITION FOR PROMOTING INTESTINAL TRACT DEVELOPMENT, COMPOSITION FOR IMPROVING PULMONARY FUNCTION AND COMPOSITION FOR ENHANCING IMMUNE FUNCTION | May 18, 2021 | Abandoned |
Array
(
[id] => 17183881
[patent_doc_number] => 20210330766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => Albumin-Free Botulinum Toxin Formulations
[patent_app_type] => utility
[patent_app_number] => 17/322901
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322901 | Albumin-free botulinum toxin formulations | May 17, 2021 | Issued |
Array
(
[id] => 18536110
[patent_doc_number] => 20230241197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => PROTEIN MOLECULE USEFUL FOR ANTI-PSEUDOMONAS AERUGINOSA VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/927199
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927199 | PROTEIN MOLECULE USEFUL FOR ANTI-PSEUDOMONAS AERUGINOSA VACCINE | May 12, 2021 | Abandoned |
Array
(
[id] => 18483672
[patent_doc_number] => 20230210973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION
[patent_app_type] => utility
[patent_app_number] => 17/998194
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -107
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998194 | PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION | May 9, 2021 | Pending |
Array
(
[id] => 18596058
[patent_doc_number] => 20230270849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => click OMVs
[patent_app_type] => utility
[patent_app_number] => 17/923257
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923257
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923257 | click OMVs | May 6, 2021 | Pending |
Array
(
[id] => 17050743
[patent_doc_number] => 20210260177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/241603
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 109961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241603
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241603 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF | Apr 26, 2021 | Abandoned |
Array
(
[id] => 18451926
[patent_doc_number] => 20230193205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => GENE MODIFIED FIBROBLASTS FOR THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/996109
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -142
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996109 | GENE MODIFIED FIBROBLASTS FOR THERAPEUTIC APPLICATIONS | Apr 18, 2021 | Pending |
Array
(
[id] => 18496180
[patent_doc_number] => 20230218734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND DIAGNOSING MYCOBACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/996688
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996688 | COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND DIAGNOSING MYCOBACTERIAL INFECTIONS | Apr 18, 2021 | Abandoned |
Array
(
[id] => 17005455
[patent_doc_number] => 20210236616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => METHOD FOR TREATING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/234379
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234379 | Method for treating fibromyalgia and chronic fatigue syndrome | Apr 18, 2021 | Issued |
Array
(
[id] => 17036691
[patent_doc_number] => 20210253649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS AND CELL-TARGETING MOLECULES COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/233911
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 141002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233911 | De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same | Apr 18, 2021 | Issued |
Array
(
[id] => 18872369
[patent_doc_number] => 11860163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Methods and compositions for identifying and treating subjects at risk for poor CAR T cell therapy response
[patent_app_type] => utility
[patent_app_number] => 17/229184
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 15
[patent_no_of_words] => 14968
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 318
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/229184 | Methods and compositions for identifying and treating subjects at risk for poor CAR T cell therapy response | Apr 12, 2021 | Issued |
Array
(
[id] => 18162977
[patent_doc_number] => 20230029570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => Bacillus Strain for Applications in Agriculture, Livestock Health and Environmental Protection
[patent_app_type] => utility
[patent_app_number] => 17/771704
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771704
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771704 | Bacillus Strain for Applications in Agriculture, Livestock Health and Environmental Protection | Apr 12, 2021 | Pending |
Array
(
[id] => 17140234
[patent_doc_number] => 20210308245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => CONSTRUCTION AND USE OF TANDEM EPITOPE POLYPEPTIDE OF OUTER MEMBRANE PROTEIN OF CAMPYLOBACTER JEJUNI, GENE, RECOMBINANT PLASMID AND RECOMBINANT BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/220355
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220355
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/220355 | CONSTRUCTION AND USE OF TANDEM EPITOPE POLYPEPTIDE OF OUTER MEMBRANE PROTEIN OF CAMPYLOBACTER JEJUNI, GENE, RECOMBINANT PLASMID AND RECOMBINANT BACTERIA | Mar 31, 2021 | Abandoned |